Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1038/s41577-021-00536-9 http://scihub22266oqcxt.onion/10.1038/s41577-021-00536-9 33824483!8023349!33824483     free     free     free Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Nat+Rev+Immunol 2021 ; 21 (5): 319-329 Nephropedia Template TP {{tp|p=33824483|t=2021. Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19 |pdf=|usr=}}{{33824483}} gab.com Text Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19 JO: Nat Rev Immunol http://www.kidney.de/pget.php?&tw=1&pmid=33824483 #FOAvip Coronavirus disease 2019 (COVID-19) is a clinical syndrome caused by infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Patients with severe disease show hyperactivation of the immune system, which can affect multiple organs besides the lungs. Here, we propose that SARS-CoV-2 infection induces a process known as immunothrombosis, in which activated neutrophils and monocytes interact with platelets and the coagulation cascade, leading to intravascular clot formation in small and larger vessels. Microthrombotic complications may contribute to acute respiratory distress syndrome (ARDS) and other organ dysfunctions. Therapeutic strategies aimed at reducing immunothrombosis may therefore be useful. Several antithrombotic and immunomodulating drugs have been proposed as candidates to treat patients with SARS-CoV-2 infection. The growing understanding of SARS-CoV-2 infection pathogenesis and how it contributes to critical illness and its complications may help to improve risk stratification and develop targeted therapies to reduce the acute and long-term consequences of this disease. Twit Text FOAVip Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19 ????Nat Rev Immunol http://www.kidney.de/pget.php?&tw=1&pmid=33824483 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33824483 #FOAvip English Wikipedia <ref>{{Cite pmid|33824483}}</ref> Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19 #MMPMID33824483 Bonaventura A; Vecchie A; Dagna L; Martinod K; Dixon DL; Van Tassell BW; Dentali F; Montecucco F; Massberg S; Levi M; Abbate A Nat Rev Immunol 2021[May]; 21 (5): 319-329 PMID33824483show ga Coronavirus disease 2019 (COVID-19) is a clinical syndrome caused by infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Patients with severe disease show hyperactivation of the immune system, which can affect multiple organs besides the lungs. Here, we propose that SARS-CoV-2 infection induces a process known as immunothrombosis, in which activated neutrophils and monocytes interact with platelets and the coagulation cascade, leading to intravascular clot formation in small and larger vessels. Microthrombotic complications may contribute to acute respiratory distress syndrome (ARDS) and other organ dysfunctions. Therapeutic strategies aimed at reducing immunothrombosis may therefore be useful. Several antithrombotic and immunomodulating drugs have been proposed as candidates to treat patients with SARS-CoV-2 infection. The growing understanding of SARS-CoV-2 infection pathogenesis and how it contributes to critical illness and its complications may help to improve risk stratification and develop targeted therapies to reduce the acute and long-term consequences of this disease. |Blood Coagulation/immunology[MESH] |Blood Platelets/immunology[MESH] |COVID-19/*immunology/*pathology[MESH] |Critical Illness/therapy[MESH] |Cytokine Release Syndrome/immunology/*pathology[MESH] |Endothelium, Vascular/pathology[MESH] |Fibrinolytic Agents/therapeutic use[MESH] |Humans[MESH] |Immunity, Innate/immunology[MESH] |Lung/blood supply/pathology/virology[MESH] |Monocytes/immunology[MESH] |Neutrophils/immunology[MESH] |SARS-CoV-2/immunology/pathogenicity[MESH]Endothelial dysfunction and immunothrombosis as key pathogenic mechani(epmc).pdf DeepDyve Pubget Overpricing